Revenue | ₹175.48Cr |
Net Profits | ₹18.24Cr |
Net Profit Margins | 10.39% |
SMS Pharmaceuticals Ltd’s revenue jumped 7.68% since last year same period to ₹175.48Cr in the Q3 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated -11.4% fall in its revenue since last 3-months.
SMS Pharmaceuticals Ltd’s net profit jumped 58.89% since last year same period to ₹18.24Cr in the Q3 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 29.36% jump in its net profits since last 3-months.
SMS Pharmaceuticals Ltd’s net profit margin jumped 47.56% since last year same period to 10.39% in the Q3 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 46% jump in its net profit margins since last 3-months.
The revenue for SMS Pharmaceuticals Ltd in the Q3 results 2024 was ₹175.48Cr.
The net profit for SMS Pharmaceuticals Ltd in the Q3 results 2024 was ₹18.24Cr.
The net profit margin for SMS Pharmaceuticals Ltd in the Q3 results 2024 was 10.39%.
The revenue for SMS Pharmaceuticals Ltd in the Q3 results 2023 was ₹162.97Cr.
The net profit for SMS Pharmaceuticals Ltd in the Q3 results 2023 was ₹11.48Cr.
The net profit margin for SMS Pharmaceuticals Ltd in the Q3 results 2023 was 7.04%.